Agenda

2022 Summit on Cancer Health Disparities

In-person conference:

 April 29, 2022 – May 01, 2022 

 

📍Grand Hyatt Seattle, Seattle, WA

Conference Chairs: David Aboulafia, MD, Edith P. Mitchell, MD, and Hannah Linden, MD, FACP

All times listed below are in Pacific Standard Time.

APRIL 29, 2022

3:00 PM – 3:15 PM PST: Welcome

Session 1: 3:15 PM – 4:15 PM PST: Access to insurance and cancer disparities

Moderator: Hannah Linden, MD, FACP

3:15 – 3:30 PM PST: Access to insurance and access to cancer care – Amy Davidoff, PhD, MS

3:30 – 3:45 PM PST: ACA and access to cancer care – J. Richard Goss, MD, MPH, FACP

3:45 – 4:00 PM PST: Experience from a county hospital – Hannah Linden, MD, FACP

4:00 – 4:15 PM PST: Panel discussion / Q&A

Session 2: 4:15 PM – 5:15 PM PST: Cancer care disparities – training the next generation

Moderator: Chandrikha Chandrasekharan, MBBS

4:15 – 4:25 PM PST: Career in cancer care disparities – Narjust Duma, MD

4:25 – 4:35 PM PST: Funding opportunities for disparities research – Edith Mitchell, MD

4:35 – 5:15 PM PST: Panel discussion – Manali Indravadan Patel, MD, MPH, MS, Molly Tokaz, MD, Lisa Tachiki, MD

5:15 PM to 6:30 PM PST: Roundtable discussion – Access to care by practice setting

Moderator: Rachna Shroff, MD

Keynote Speech: Ana Maria Lopez, MD, MPH, MACP, FRCP

Panelists: Shailender Bhatia, MD, Joseph Rosales, MD, Michael Wagner, MD, Sibel Blau, MD

APRIL 30, 2022

Session 1: 08:00 AM to 09:45 AM PST: Technology and cancer disparities

Moderator: Jack West, MD

8:00 – 8:15 AM PST: Telemedicine for cancer care after the COVID-19 pandemic: lessons learned – Jack West, MD

8:15 – 8:30 AM PST: Mitigating disparities potentially magnified by telemedicine: Addressing “Techquity” – Joy Feliciano, MD

8:30 – 8:45 AM PST: Project ECHO and delivering global oncology – Ellen Baker, MD, MPH

8:45 – 9:00 AM PST: Panel discussion, Q/A on telemedicine addressing or worsening disparities 

9:00 – 9:15 AM PST: Asynchronous integration of an oncology subspecialist with local delivery of cancer care: The AccessHope experience – Afsaneh Barzi, MD, PhD

9:15 – 9:30 AM PST: Virtual tumor boards to bring subspecialist care beyond tertiary care centers – Ghassan Abou-Alfa, MD, MBA

9:30 – 9:45 AM PST: Panel discussion, Q/A on models for overcoming geographic barriers to increasingly complex oncology delivery

9:45 – 10:15 AM PST: Break 

Session 2: 10:15 AM to 12:00 PM PST: Breast Cancer Disparities Session – sponsored by BCRF

Moderator: Julie Gralow, MD 

10:15 – 10:30 AM PST: Lancet Commission on Women and Cancer – Ophira Ginsburg, MD

10:30 – 10:45 AM PST: WHO Global Breast Cancer Initiative – Ben Anderson, MD

10:45 – 11:00 AM PST: Overcoming Racial, Ethnic, and Socioeconomic Disparities in Breast Cancer Care in the US – Edith Mitchell, MD

11:00 – 11:15 AM PST: University of Washington Equity Initiative – Rachel Yung, MD

11:15 – 12:00 PM PST: Panel Discussion – Bridgette Hempstead

12:00 – 01:00 PM PST: Lunch

Session 3: 1:00 PM to 2:15 PM PST: Professional Societies’ initiatives in improving cancer health disparities

Moderator: Edith Mitchell, MD

1:00 – 1:30 PM PST: Society President or representative presentations

  • ASCO’s efforts in improving access to cancer care – Everett Vokes, MD, FASCO
  • ASCP’s efforts in improving access to cancer care – Danny A. Milner, Jr, MD, MSc(Epi), FASCP
  • EONS’ efforts in improving access to cancer care – Johan deMunter, EONS President
  • ASTRO’S efforts in improving access to cancer care – Geraldine Jacobson, MD, MPH, MBA, FASTRO
  • NCCN’s efforts in improving access to cancer care – Robert Carlson, MD

1:30 – 2:15 PM PST: Panel discussion 

2:15 PM to 2:45 PM PST: Break

Session 4: 2:45 PM to 4:15 PM PST: Cancer Health Disparities in the LGBTQ population

Moderator: David Aboulafia, MD

2:45 – 3:00 PM PST: Anal cancer screening among people living with HIV: Lessons from the ANCHOR study – Joel Palefsky, MD 

3:00 – 3:15 PM PST: Cultural barriers to equity and cancer disparities among sexual and gender minorities – Matthew Schabath, PhD

3:15 – 3:30 PM PST: Cancer screening among women living with HIV – Liz Chiao, MD

3:30 – 3:45 PM PST: Engaging LGBTQ community in research efforts – Michael Louella, AIDS Clinical Trial Unit Outreach Coordinator 

3:45 – 4:15 PM PST: Panel discussion – Bakari Salim

6:00 – 9:00 PM PST: Gala dinner

MAY 01, 2022

Session 1: 8:00 AM to 9:15 AM PST: Global Oncology 

Moderators: Aparna Parikh, MD, MS & Bhawna Sirohi, MBBS, FRCP

8:00 – 8:15 AM PST: The promise of Universal Health Coverage (UHC) for global cancer: moving from challenges to solutions – Professor Richard Sullivan, PhD

8:15 – 8:30 AM PST: Levelling the field in cancer research to control global cancer burden – Nazik Hammad, MD, MSc, MEHP, FACP

8:30 – 8:45 AM PST: Founding of cancer care and research institute in Jamaica – Dingle Spence, BSc, MBBS, DMRT, Dip Pall. Med, FRCR

8:45 – 9:15 AM PST: Panel discussion – Manoj P. Menon, MD, MPH

9:15 – 9:45 AM  PST: Break & Abstract Session 1

9:15 – 9:21 AM – Poster: 

  • Prostate Cancer (PCa) in Male & Breast Cancer (BCa) in Female Make largest Cancer Pool in the World & in the EU28+EFTA
  • An Evaluation of Health Disparities Among Breast Cancer Patients and the Relationship to Emergency Department Utilization

9:21 – 9:27 AM – Poster: 

  • A Methodology to Quality Improvement in Patient Navigation, Access to Care, and Patient Education in Rural and Urban Cancer Centers
  • Addressing Latinx CANcer Care Equity (ALCANCE) Randomized Controlled Trial: baseline findings from a community health worker led intervention

9:27 – 9:33 AM – Poster:

  • COMPARISON OF SET-UP ERRORS IN CONFORMAL RADIOTHERAPY OF CARCINOMA CERVIX USING DIFFERENT IMMOBILIZATION TECHNIQUES- A PROSPECTIVE STUDY FROM A TERTIARY CARE HOSPITAL IN EASTERN INDIA
  • Factors affecting utilization of chemotherapy in Acute Lymphoblastic Leukemia (ALL): A SEER database study

9:33 – 9:39 AM – Poster: 

  • Healthcare Costs and Financial Barriers to Diagnosis and Treatment of People Living with HIV-Associated Kaposi’s Sarcoma in Western Kenya: A Qualitative Analysis
  • FACTORS INFLUENCING THE ACCEPTANCE OF BREAST CONSERVING SURGERY IN EARLY BREAST CANCER PATIENTS IN RURAL SOUTHERN INDIA – A PROSPECTIVE STUDY

9:39 – 9:45 AM – Poster:

  • Stigma in the Diagnosis and Treatment of HIV-associated Kaposi’s Sarcoma
  • Barriers and facilitators to genomic testing uptake and cancer clinical trial enrollment in historically underrepresented patient populations – Clinician and research staff perceptions

Session 2: 9:45 – 11:00 AM PST: Clinical Trials and Disparities in cancer care

Moderator: Chadi Nabhan, MD, MBA, FACP

9:45 – 10:00 AM PST: Keynote speech – Joseph Unger, PhD, MS

10:00 – 11:00 AM PST: Panel discussion – Mark Pegram, MD, MD, Shilpen Patel, MD, Mark Lewis, MD

Session 3: 11:05 AM to 12:05 PM PST: Precision oncology/cellular therapies and cancer disparities

Moderator: Vivek Subbiah, MD

11:05 – 11:15 AM PST: Globalization of Precision Oncology: Future outlook and challenges – Vivek Subbiah, MD

11:15 – 11:25 AM PST: Implementation of Precision medicine in Lung Cancer: Challenges – Rafael Santana-Davila, MD

11:25 – 11:35 AM PST: Precision Medicine in Bladder Cancer: Challenges and opportunities – Petros Grivas, MD, PhD

11:35 – 11:45 AM PST: Health Economics of Precision Oncology – Dipesh Uprety, MD

11:45 – 11:55 AM PST: Genetics and high risk hereditary cancers and Precision Medicine: Challenges – Marianne Dubard-Gault, MD, MS

11:55 – 12:05 AM PST: Q&A

12:05 – 01:00 PM PST: Lunch & Abstract Session 2

12:05 – 12:15PM – Oral: 

  • Disparities in breast cancer genomic signature ordering practices in the United States

12:15 – 12:25 PM – Oral: 

  • National Coalition for Cancer Survivorship’s State of Survivorship Survey: Disparities in Quality of Care

12:25 – 12:35 PM – Oral: 

  • Assessing disparities in social determinants of health between Hispanics/LatinX and Non-Hispanic Whites

12:35 – 12:41 PM – Poster: 

  • Barriers and facilitators to genomic testing uptake and cancer clinical trial enrollment in historically underrepresented patient populations – Clinician and research staff perceptions
  • Delaying Filgrastim Administration after Autologous Stem Cell Transplant in Patients with Multiple Myeloma

12:41 – 12:47 PM- Poster: 

  • Disparity of race reporting and representation among US FDA approved tyrosine kinase inhibitors
  • EVALUATION OF THE PALLIATIVE PROGNOSTIC INDEX (PPI) IN CANCER PATIENTS

12:47 – 12:53 PM – Poster: 

  • Predict score and luminal localized breast cancer in young women
  • Epidemiological and clinical characteristics of male breast cancer in the southern of Tunisia: A single center experience

Session 4: 1:00 – 2:00 PM PST: Plenary lecture – Expediting adoption of practice-changing research in community practice – current challenges and potential solutions

Moderator: Shaji Kumar, MD

Plenary Speaker 1: 

Introduction: Natasha Hunter, MD

Speaker: Nancy E. Davidson, MD

Plenary Speaker 2: 

Introduction: Aparna Parikh, MD, MS

Speaker: Wui-Jin Koh, MD

Panelists: Edward L. Briercheck, MD, Tony Blau, MD

2:00 – 2:15 PM PST: Break

Session 5: 2:15 – 3:30 PM PST: Imaging in LMIC

Moderator: Saurabh Jha, MD

Panelists: Farouk Dako, MD, MPH, Ravi Shrestha, PhD, Chiranjiv Singh, Norissa Haynes, MD, MPH